Skip to content

Referral of Patients With Biological Abnormalities to an Emergency Department

Referral of Patients With Biological Abnormalities to an Emergency Department : ORA

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07405996
Acronym
ORA
Enrollment
5000
Registered
2026-02-12
Start date
2026-02-01
Completion date
2027-02-01
Last updated
2026-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biological Abnormality, Emergency Department Visit, General Practitioner

Brief summary

Biological testing is an essential part of general medical practice and plays a role in 60% to 70% of diagnoses. 68.5% of prescriptions are written by general practitioners, and one in seven general medical consultations ends with a prescription for biological testing. The study of patient trajectories is a recent emerging topic in the literature, encompassing general concepts. The angle most often taken is medico-economic and focused on specific chronic conditions such as diabetes, cancer, or cardiovascular disease. To our knowledge, there are a number of referrals to emergency departments by general practitioners for patients with biological abnormalities. However, to our knowledge, no study to date has attempted to quantify these specific referrals.

Detailed description

want to establish a register of biological anomaly referrals by general practitioners to emergency departments. This study will enable us to estimate the number of patients whose referral could have been handled differently, allowing us to develop dedicated care pathways, specialized training in outpatient settings, or targeted communications, ultimately leading to better patient referral and reducing inappropriate use of emergency services.

Interventions

None listed

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient presenting at an emergency department participating in the IOA (nurse coordinating reception) system with the reason for referral "Abnormal laboratory results.

Exclusion criteria

* minor patients (\<18 years old) * expression of the patient's opposition to the collection of data relating to their hospital stay.

Design outcomes

Primary

MeasureTime frameDescription
Type of biological abnormality and severity levelImmediately upon admission to the emergency roomThe primary evaluation criterion is the type of biological abnormality sent to the emergency department and its severity (depth or elevation).

Countries

France

Contacts

CONTACTAndreia CARVALHO DE FREITAS
projet-recherche-clinique@chr-metz-thionville.fr0033387553323
CONTACTLaure ABENSUR VUILLAUME
laure.abensur-vuillaume@chr-metz-thionville.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026